HLA-C and cancer: TAA is an autoantigen expressed in normal tissues and overexpressed in various cancers, including cancer-testis antigens, tissue-differentiation neoantigens, and overexpression antigens.14–16 Contrarily, TSA is directly produced from numerous non-synonymous somatic mutations that can increase MHC presentation to antigen epitopes or alter their T cell receptor (TCR) recognition.